First Trust Nasdaq Lux Digital Health Solutions ETFの空売り状況は、投資家がFirst Trust Nasdaq Lux Digital Health Solutions ETFの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

First Trust Nasdaq Lux Digital Health Solutions ETF (NASDAQ:EKG), 空売り情報

Healthcare

Consumer Defensive

The First Trust Nasdaq Lux Digital Health Solutions ETF (the Fund) seeks investment results that correspond generally to the price and yield (before the Funds fees and expenses) of an equity index called the Nasdaq Lux Health Tech Index (the Index)

Resmed Inc.

Intuitive Surgical Inc

Iqvia Holdings Inc.

Veeva Systems Inc

Dexcom Inc.

Insulet Corp

Natera Inc

Hologic Inc.

Qiagen NV

Exact Sciences Corp.

Hims & Hers Health Inc

Globus Medical Inc

Doximity, Inc.

First Trust Nasdaq Lux Digital Health Solutions ETF

CARDIOCOM SLTNS INC by CardioCom Solutions, Inc.

CardioComm Solutions Inc

Raymond James analyst Jayson Bedford maintains Merit Medical Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMSI#NASDAQ">MMSI</a>) with a Outperform and lowers the price target from $116 to $108.

News

Price Target

Analyst Ratings

MMSI

Raymond James Maintains Outperform on Merit Medical Systems, Lowers Price Target to $108

Raymond James analyst Andrew Cooper maintains Integer Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITGR#NYSE">ITGR</a>) with a Outperform and raises the price target from $145 to $150.

ITGR

Raymond James Maintains Outperform on Integer Holdings, Raises Price Target to $150

Stephens &amp; Co. analyst Terry McEvoy maintains Associated Banc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASB#NYSE">ASB</a>) with a Equal-Weight and lowers the price target from $28 to $26.

Stephens & Co. Maintains Equal-Weight on Associated Banc, Lowers Price Target to $26

Raymond James analyst Michael Rose maintains Business First Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFST#NASDAQ">BFST</a>) with a Outperform and lowers the price target from $30 to $28.

BFST

Raymond James Maintains Outperform on Business First Bancshares, Lowers Price Target to $28

Raymond James analyst Savanthi Syth maintains American Airlines Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) with a Outperform and lowers the price target from $15 to $14.

Raymond James Maintains Outperform on American Airlines Group, Lowers Price Target to $14

General

GOOG

GOOGL

Alphabet Files For Mixed Shelf Offering; Size Not Disclosed

Stephens &amp; Co. analyst Matt Olney maintains Business First Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFST#NASDAQ">BFST</a>) with a Overweight and lowers the price target from $34 to $32.

Stephens & Co. Maintains Overweight on Business First Bancshares, Lowers Price Target to $32

W.W. Grainger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWW#NYSE">GWW</a>) has outperformed the market over the past 5 years by 14.76% on an annualized basis producing an average annual return of 28.63%. Currently, W.W. Grainger has a market capitalization of $49.16 billion. 
Buying $100 In GWW: If an investor had bought $100 of GWW stock 5 years ago, it would be worth $363.45 today based on a price of $1020.59 for GWW at the time of writing.
<h3>W.W. Grainger's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745597718_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much You Would Have Made Owning W.W. Grainger Stock In The Last 5 Years

Stephens &amp; Co. analyst Justin Long maintains Ryder System (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/R#NYSE">R</a>) with a Equal-Weight and lowers the price target from $168 to $150.

Stephens & Co. Maintains Equal-Weight on Ryder System, Lowers Price Target to $150

Oppenheimer analyst Martin Yang maintains Electronic Arts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EA#NASDAQ">EA</a>) with a Outperform and raises the price target from $140 to $170.

Oppenheimer Maintains Outperform on Electronic Arts, Raises Price Target to $170

Oppenheimer analyst Jason Helfstein maintains Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) with a Outperform and raises the price target from $185 to $200.

Oppenheimer Maintains Outperform on Alphabet, Raises Price Target to $200

Both Rivian Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) and Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) have new, more affordable electric vehicles on the horizon and that could be what's needed to fight off a <a href="https://www.benzinga.com/tech/25/04/44784826/jeff-bezos-backed-slate-auto-to-take-on-elon-musks-tesla-rivian-with-budget-ev-pickup-report">new EV startup </a>backed by Amazon.com founder Jeff Bezos.
What Happened: Michigan-based startup Slate Auto has been unveiling concept versions of its electric pickup truck over the past few weeks and held an <a href="https://www.benzinga.com/tech/25/04/45006513/jeff-bezos-backed-tesla-rival-unveils-20000-modular-ev-pickup-truck-with-customization-at-the-forefront">event on Thursday </a>that highlighted more details of the company's future.
Slate Auto refers to its base model as the "Blank Slate" model, according to a TechCrunch <a href="https://techcrunch.com/2025/04/21/bezos-backed-startup-designed-an-ev-that-can-change-like-a-transformer/">report</a>. The company has trademarked "We Built It. You Make It" and the concept versions might explain why.
The startup, which counts Amazon.com founder Bezos as an early investor, may use a marketing strategy of highlighting how the company's model can transform from an electric pickup truck to an SUV, creating two vehicles in one.
Called a "Transformer-like vehicle" by <a href="https://techcrunch.com/2025/04/24/bezos-backed-slate-auto-debuts-analog-ev-pickup-truck-that-is-decidedly-anti-tesla/">TechCrunch</a>, the new vehicle could quickly catch the attention of new vehicle shoppers looking for either an electric pickup truck or an electric SUV.
One auto journalist wrote that the truck "is unlike any new vehicle I've ever seen, not just in my decade as a car journalist, but in my entire lifetime."
On Thursday, the unveiling of the Slate Auto truck showed how basic the customizable vehicle is, with TechCrunch reporting the vehicle has manual windows and no infotainment screen. 
Also showcased at Thursday's event was how the vehicle can go from a two-seater pickup to a five-seater SUV. The company said buyers could complete this transformation themselves with "no mechanics certification required."
Another key detail from the unveiling event was the price, with the first Slate Auto truck model expected to cost under $20,000 with federal EV tax credits. The truck is expected to be available by the end of 2026. Buyers could customize the vehicle with add-ons that would elevate the starting price.
Slate will offer around 100 different accessories at launch that can personalize the base model, along with "starter packs" of basic accessories. The base version has an estimated range of 150 miles, with an option to upgrade to a larger battery with 240 miles of range.
"We are building the affordable vehicle that has long been promised but never been delivered," Slate Auto CEO Chris Barman said at the event.
Read Also: <a href="https://www.benzinga.com/25/02/43867210/rivian-automotive-q4-earnings-highlights-revenue-beat-eps-beat-2025-guidance-truly-transformational-product-r2-coming">Rivian Automotive Q4 Earnings Highlights: Revenue Beat, EPS Beat, 2025 Guidance, R2 Update</a>
Why It's Important: Traditional automakers and electric vehicle companies have launched models with many tech-focused bells and whistles inside and outside.
Rivian CEO RJ Scaringe has<a href="https://www.benzinga.com/trading-ideas/25/04/44598035/rivian-ceo-says-us-needs-more-under-50k-evs-to-catch-up-to-china-you-have-to-have-the-plumbing-right"> argued for years</a> that the electric vehicle sector needs more sub-$50,000 vehicles. Now an upcoming competitor could have the right idea by starting basic and letting customers choose their options.
With a starting price point of under $20,000, the Slate vehicle could be considerably cheaper than other electric pickup trucks, like the ones below, with starting prices <a href="https://www.kbb.com/electric-car/best-electric-trucks/">from </a>Kelley Blue Book.
<ul>
<li>F-150 Lightning: $57,090</li>
<li>Chevrolet Silverado EV: $75,195</li>
<li>R1T: $71,700</li>
<li>Cybertruck: $82,235</li>
</ul>
Ford Motor Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) could also be impacted by Slate Auto, with the F-150 Lightning ranking eighth for overall U.S. EV market share in<a href="https://www.benzinga.com/25/04/44802015/us-electric-vehicle-sales-up-11-in-q1-as-tesla-declines-the-winners-and-losers"> the first quarter</a> and<a href="https://www.benzinga.com/news/25/01/42986863/us-electric-vehicle-sales-hit-record-1-3-million-units-in-2024-despite-tesla-declines-top-10-bestsel"> sixth in 2024.</a>
The Cybertruck ranked 10th among all EVs in the U.S. in the first quarter and was fifth in 2024.
Rivian did not have a top 10 vehicle in the first quarter, with its SUV, the R1S, ranking 10th in 2024 with 26,934 units sold.
Rivian had total deliveries of 51,579 vehicles in 2024 and hopes its next models dramatically increase that figure in the future.
While Slate Auto is only a startup and has not delivered any vehicles, the company's early pricing and customizable features could scare other electric vehicle manufacturers.
You may not be a billionaire like Jeff Bezos, but you can uncover hidden gems in the stock market using our proprietary data and pattern recognition — <a href="https://www.benzinga.com/markets/commodities/25/04/44651693/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">check out five stocks flying under the radar that deserve your attention.</a>

AMZN

RIVN

TSLA

Bezos Vs. Tesla Vs. Rivian Stock? Company Backed By Amazon Founder Can Turn $20K EV Truck Into SUV

Stephens &amp; Co. analyst Terry McEvoy maintains Civista Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIVB#NASDAQ">CIVB</a>) with a Equal-Weight and raises the price target from $24 to $25.

CIVB

Stephens & Co. Maintains Equal-Weight on Civista Bancshares, Raises Price Target to $25

Oppenheimer analyst Hartaj Singh maintains Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) with a Outperform and lowers the price target from $132 to $125.

GILD

Oppenheimer Maintains Outperform on Gilead Sciences, Lowers Price Target to $125

Oppenheimer analyst Timothy Horan maintains Comcast (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) with a Outperform and lowers the price target from $55 to $38.

CMCSA

Oppenheimer Maintains Outperform on Comcast, Lowers Price Target to $38

<ul>
<li>UK Medicines and Healthcare products Regulatory Agency (MHRA) authorisation based on FELIX clinical trial of obecabtagene autoleucel in adult patients with r/r B-ALL1</li>
<li>AUCATZYL&#xAE; licensed from MHRA under ‘conditional marketing authorisation', meaning that the MHRA will review new efficacy and safety information at least once every year1</li>
</ul>
Investors, US and UK National, Medical and Industry media only
LONDON, April 25, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUTL#NASDAQ">AUTL</a>), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies and candidates, announces today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted conditional marketing authorisation for AUCATZYL&#xAE;&nbsp;(obecabtagene autoleucel) for the treatment of adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (r/r B-ALL).

AUTL

MHRA Grants Conditional Marketing Authorisation For Autolus Therapeutics' AUCATZYL For Treatment Of Adult Patients With Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

Oppenheimer analyst Owen Lau maintains TransUnion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRU#NYSE">TRU</a>) with a Outperform and raises the price target from $93 to $96.

Oppenheimer Maintains Outperform on TransUnion, Raises Price Target to $96

Stephens &amp; Co. analyst Terry McEvoy maintains Old Second Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSBC#NASDAQ">OSBC</a>) with a Overweight and lowers the price target from $22 to $20.

OSBC

Stephens & Co. Maintains Overweight on Old Second Bancorp, Lowers Price Target to $20

The airline industry is back in the headlines, though not in a way that would make investors cheer. Another batch of earnings releases from large U.S. carriers—American Airlines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>), Southwest Airlines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>), and Alaska Air (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALK#NYSE">ALK</a>)—has brought a somber message: the skies are cloudy for forward-looking guidance. As these airlines take back their 2025 outlooks in response to escalating macroeconomic uncertainty, investors holding <a href="https://www.benzinga.com/etfs">airline-themed ETFs</a> are replanning their altitude.
ETFs In Focus
These are the three most susceptible ETFs most exposed to the turbulence shaking up the skies:
U.S. Global Jets ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JETS#NYSE">JETS</a>)
This is the most widely held airline ETF among most investors, providing access to a portfolio of global airline shares, with a heavy U.S. bias. JETS has large stakes in Delta Air Lines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>), United Airlines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NYSE">UAL</a>), American, and Southwest—all of which have watched their share prices spiral downward more than 20% on an average so far into 2025. Needless to say, JETS has declined sharply year to date, almost 23%, both as a result of weaker domestic demand and increasing economic headwinds.
Also Read: <a href="https://www.benzinga.com/etfs/specialty-etfs/25/04/44993378/schd-is-down-but-its-dividend-is-up-and-these-2-etfs-are-quietly-catching-up">SCHD Is Down, But Its Dividend Is Up And These 2 ETFs Are Quietly Catching Up</a>
iShares Transportation Average ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/IYT#BATS">IYT</a>)
Although not airline-centric, IYT does have high exposure to airlines, along with freight and logistics stocks. The fund has been stressed by weakness within the passenger air travel component, as air travel demand between the U.S. and other countries especially Canada, has been affected due to tariffs and is susceptible to additional challenges if the slowdown permeates to cargo and global travel.
SPDR S&amp;P Transportation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XTN#NYSE">XTN</a>)
XTN provides equal-weighted exposure to the wider transportation space, including regional carriers. It&#8217;s more attuned to under-the-radar participants such as Alaska Air, which have fallen harder than their big-cap peers because they&#8217;ve been more dependent on domestic routes—now the weakest part of the market.
Guidance Cuts
Although first-quarter results were largely better than projected, the actual theater of action is in the empty forecast columns.
American Airlines topped revenue expectations and reported a smaller-than-expected Q1 loss, but <a href="https://www.benzinga.com/25/04/44982328/american-airlines-flies-into-uncertainty-q1-revenue-miss-2025-outlook-pulled-but-debt-plan-on-track">withdrew its full-year forecast</a>, stating visibility is limited and clouds are dense.
Southwest seconded that view, regardless of record Q1 revenue, <a href="https://www.benzinga.com/general/travel/25/04/44968055/southwest-airlines-tosses-out-profit-guidance-amid-macroeconomic-uncertainty-shares-slide-despite-better-than-expected-q1-results">withdrawing earnings guidance for 2025 and 2026</a> after experiencing demand weaken over the course of the quarter.
Alaska Air fell <a href="https://www.benzinga.com/25/04/44976464/alaska-air-hit-by-demand-dip-in-q1-loss-skips-fy25-guidance-update-amid-uncertainty">short on revenue and sharply reduced Q2 expectations</a>, stating it is anticipating a 6 percentage point revenue hit from soft demand.
If investors were expecting clarity, they received fog instead.
Macro Headwinds And Tariff Crosswinds
Aside from consumer demand, geopolitics and trade tensions are also blowing fiercely. Tariffs imposed by President Donald Trump have contributed to growing economic uncertainty, with spillovers affecting airline sentiment. 
Boeing, meanwhile, is seeking to reroute dozens of undeliverable planes originally destined for Chinese customers. &#8220;We have many customers who want near-term deliveries, so we plan to redirect the supply to the stable demand. And we are not going to continue to build aircraft (and ship it) to customers who will not take them,&#8221; Boeing CEO Kelly Ortberg explained <a href="https://www.benzinga.com/markets/equities/25/04/44970516/boeing-adjusts-strategy-amid-trump-tariff-fallout-ceo-kelly-ortberg-says-wont-build-aircraft-for-customers-who-will-not-take-them-as-china-halts-deliveries">in the earnings call.</a>
So far this year, American Airlines has fallen 43%, Southwest is down 22%, Delta and United have slid 30% and 28%, respectively.
The domestic demand drag is evident across the board. Airlines are hoping that international and premium segments, currently holding up, don't catch the same cold, as expressed by TD Cowen analyst Tom Fitzgerald, <a href="https://www.barrons.com/articles/american-southwest-airlines-earnings-stock-price-498f8b9c">cited </a>by Barron&#8217;s. But that's a risky bet in a macro environment where clarity is more elusive than a free in-flight upgrade.
What's Next For Airline ETFs?
Investors are struggling with mixed signals: strong near-term performance in certain segments vs. gigantic uncertainty to come. Fitzgerald warned that airline stocks are likely to remain range-bound until more definitive economic data are available, citing risks to second-half 2025 and 2026 earnings estimates.
While airline ETFs might still be a long-term bargain—currently, investors are in a holding pattern. Until economic skies brighten, it may be best to have that seatbelt tightly buckled.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/04/44947467/voo-vs-vti-buffett-approves-this-battle-for-your-portfolio">VOO Vs. VTI: Buffett Approves This Battle For Your Portfolio</a></li>
</ul>
Photo: Shutterstock

Sector ETFs

ETFs

iShares Dow Jones Transportation Average Index Fund

JETS

Airline Stocks Hit Headwinds As Carriers Cut Guidance, ETFs Enter Turbulence

Oppenheimer analyst Ken Wong maintains PTC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTC#NASDAQ">PTC</a>) with a Outperform and lowers the price target from $210 to $170.

Comments

First Trust Nasdaq Lux Digital Health Solutions ETF

空売り

First Trust Nasdaq Lux Digital Health Solutions ETF (NASDAQ:EKG), 空売り情報

ニュース

パートナーシップ

ベンジンガ・グローバル